Deciphering the landscape of phosphorylated HLA-II ligands

CD4(+) T cell activation in infectious diseases and cancer is governed by the recognition of peptides presented on class II human leukocyte antigen (HLA-II) molecules. Therefore, HLA-II ligands represent promising targets for vaccine design and personalized cancer immunotherapy. Much work has been d...

Descripción completa

Detalles Bibliográficos
Autores principales: Solleder, Marthe, Racle, Julien, Guillaume, Philippe, Coukos, George, Bassani-Sternberg, Michal, Gfeller, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051626/
https://www.ncbi.nlm.nih.gov/pubmed/35494241
http://dx.doi.org/10.1016/j.isci.2022.104215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051626/
https://www.ncbi.nlm.nih.gov/pubmed/35494241
http://dx.doi.org/10.1016/j.isci.2022.104215

Ejemplares similares